Combrestatin A4 (CA4) is a potent inhibitor of tubulin polymerization and displays strong inhibitory activity on tumor cell growth. CA4 was shown to inhibit tumor growth in several cell lines including IMR32 (neuroblastoma), Hs746T (gastric carcinoma), CFPAC-1 (pancreatic carcinoma), and MCF-7 (breast cancer) with IC50 values of 2.16, 5.20, 3.46, and 18.47 nM, respectively.1 CA4 inhibits tubulin polymerization with an IC50 value of 2.2 µM.2
1
Sun, L., Vasilevich, N.I., Fuselier, J.A., et al. Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice. Anticancer Res24179-186(2004).
2
Dey, P. Chromatin remodeling, cancer and chemotherapy. Curr Med Chem132909-2919(2006).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
COc1cc(\C=C\c2ccc(OC)c(O)c2)cc(OC)c1OC
Background Reading
Dey, P. Chromatin remodeling, cancer and chemotherapy. Curr Med Chem132909-2919(2006).
Sun, L., Vasilevich, N.I., Fuselier, J.A., et al. Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice. Anticancer Res24179-186(2004).
Combrestatin A4 is available in the following screening
library: